Adicet Bio, Inc.

US$3.05As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACETHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (49.18%)
Div yield —
ROE (85.91%)
Biotechnology
Beta (5Y) 1.74
PE TTM —
TSR TTM (74.58%)
Mkt cap US$32.83M
ROIC (49.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.82
25.23%
(36.48%)
Hold 0|7|10|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.07
0.07
13.32%
1.10%
14.40%
17.21%
Revenue$M
2.914
3.073
3.137
3.064
6.16%
6.36%
7.58%
7.04%
Peers (US$32.83M)
Cap (US$)
PE
31.04M
—
Capital
TTM
5Y
10Y
Leveragex
0.957
0.212
0.181
EBIT/Intx
2.148
0.200
0.200
Own earn%
240.99
(139.82)
(144.22)
Sh yield%
51.87
36.69
36.14
Owners
Insiders/Inst%
9.70
27.01
Short interest%
4.34
SBC / revenue%
4.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
16–24
$1 testx
−0.5
Incr. ROIC%
23